Santhera Pharmaceuticals Maximum Drawdown
| SANN Stock | | | CHF 14.84 0.72 5.10% |
The Maximum Drawdown indicator for Santhera Pharmaceuticals Holding is derived from observed market data. Exchange-specific data schedules may affect the recency of readings. Santhera Pharmaceuticals has a market cap of 142.15 M, operating margin of -147.6%, current ratio of 2.19. See
World Market Map for portfolio-level analysis. Santhera Pharmaceuticals Holding can be tracked within a custom portfolio for ongoing monitoring. Portfolio construction methods define how positions are sized relative to each other. Broader economic conditions can influence Santhera Pharmaceuticals Holding's company valuation — related indicators include
signals in inflation.
Santhera Pharmaceuticals Holding has current Maximum Drawdown of 18.11. Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 18.11 | |
| MAX | = | Maximum notation for the range of returns on Santhera Pharmaceuticals |
Maximum Drawdown Peers Comparison
Maximum Drawdown Relative To Other Indicators
Santhera Pharmaceuticals Holding is rated
below average for maximum drawdown across the peer group. It is currently under evaluation for maximum drawdown across the peer group reflecting a
1.00 ratio of Maximum Drawdown to Maximum Drawdown.
The MDD is one of the most important risk measures. It measures the loss in any losing period and is usually defined as the percent retrenchment from an asset peak value to the valley value. Maximum drawdown encompasses both the period from the peak to the valley (length), and the time from the valley to a new high (recovery). It measures the largest percentage drawdown that has occurred in a given time period.
Compare Santhera Pharmaceuticals to Peers
Other Technical Indicators